BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:29 PM
 | 
Apr 20, 2010
 |  BC Extra  |  Company News

Acura falls on Acurox briefing documents

Acura Pharmaceuticals Inc. (NASDAQ:ACUR) fell $1.67 (21%) to $6.23 on Tuesday after FDA reviewers questioned the abuse deterrent properties of Acurox oxycodone/niacin in briefing documents released ahead of Thursday's advisory panel to discuss an NDA for the oral immediate-release tablet. While reviewers said the oxycodone component in Acurox is...

Read the full 236 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >